Jul 16, 2026 06:00AM
Jun 29, 2026 10:27AM
Jun 29, 2026 09:20AM
Jun 29, 2026 07:19AM
Jun 29, 2026 06:00AM
Jun 29, 2026 06:00AM
May 14, 2026 04:05PM Zymeworks authorizes $125 million share repurchase program
May 14, 2026 04:05PM
May 7, 2026 04:05PM
May 7, 2026 04:05PM
Apr 22, 2026 07:59AM
Apr 10, 2026 06:45AM
Mar 2, 2026 06:10AM
Mar 2, 2026 06:01AM Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma
Mar 2, 2026 06:01AM
Mar 2, 2026 06:00AM
Jan 12, 2026 06:00AM
Jan 12, 2026 06:00AM
Jan 12, 2026 04:06AM
Jan 11, 2026 06:00PM
Nov 19, 2025 02:40PM Zymeworks (ZYME) PT Raised to $40 at Leerink Partners
Nov 18, 2025 05:12AM
Nov 18, 2025 05:12AM
Nov 18, 2025 01:01AM
Nov 18, 2025 01:00AM
Aug 1, 2024 04:12PM
Aug 1, 2024 04:10PM
Mar 6, 2024 04:09PM Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
Nov 7, 2023 04:05PM
Aug 10, 2023 04:05PM
Aug 10, 2023 04:05PM
Jun 29, 2023 04:05PM
Jun 29, 2023 04:05PM
Apr 10, 2023 08:31AM
Apr 10, 2023 08:30AM Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors
Oct 19, 2022 06:01AM
Oct 19, 2022 06:00AM
Jun 10, 2022 09:15AM
Jun 10, 2022 09:15AM
Jun 7, 2022 08:00AM
May 19, 2022 01:41PM
May 19, 2022 01:00PM ALL BLUE CAPITAL EXPANDS ITS LEADERSHIP TEAM TO SUPPORT PROPOSED ACQUISITION OF ZYMEWORKS INC.
May 3, 2022 03:27PM
Apr 5, 2022 04:02PM
Apr 5, 2022 04:01PM
Apr 5, 2022 04:01PM
Apr 20, 2021 08:45AM
Dec 2, 2020 08:07AM
Dec 2, 2020 08:00AM Exelixis In-Licenses Iconic Therapeutics’ Tissue Factor-Targeting Antibody-Drug Conjugate Ahead of Planned Investigational New Drug Application
Sep 30, 2019 09:26AM

1,170,803 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All